Overblog
Editer l'article Suivre ce blog Administration + Créer mon blog

 


  • 1: Hong SY, Gil HW, Yang JO, Lee EY, Kim HK, Kim SH, Chung YH, Hwang SK, Lee ZW (2005). Pharmacokinetics of glutathione and its metabolites in normal subjects. J Korean Med Sci. 20(5):721-6.
  • 2: Martin HL, Teismann P (2009). Glutathione--a review on its role and significance in Parkinson's disease. FASEB J. 23(10):3263-72.
  • 3: clinical science 91 :575-582, 1996
  • 4: Nutrition reviews 54 :1-30,1996
  • 5: Kretschmar M, Klinger W (1990). The hepatic glutathione system-influences of xenobiotics. Exp Pathol. 38:145-164.
  • 6: : Corcoran GB, Wong BK (1986). Role of glutathione in prevention of acetaminophen-induced hepatotoxicity by N-acetyl-l-cysteine in vivo. J Pharmacol Exp Ther 238:54-61.
  • 7: Biaglow JE, Varnes ME, Epp ER, et al (1989). Role of glutathione and other thiols in cellular response to radiation and drugs. Drug Metab Rev. 20:1-12.
  • 8: Ketterer B, Coles B, Meyer DJ (1983). The role of glutathione in detoxication. Environ Health Perspect. 49:59-60.
  • 9: Clinical science 91 :575-582, 1996
  • 10: Abdalla DSP, Monteiro HP, Oliveira JAC, et al (1986). Activities of superoxide dismutase and glutathione peroxidase in schizophrenic and manic-depressive patients. Clin Chem. 32:805-807.
  • 11: Marshall KA, Reist M, Jenner P, el al (1999). The neuronal toxicity of sulfite plus peroxynitrite is enhanced by glutathione depletion: implications for Parkinson's disease. Free Radic Biol Med. 27:515-20.
  • 12: Jenner P, Olanow CW (1998). Understanding cell death in Parkinson's disease. Ann Neurol. 44(3 Suppl 1):S72-84.
  • 13: Merad-Boudia M, Nicole A, Santiard-Baron D, et al. Mitochondrial impairment as an early event in the process of apoptosis induced by glutathione depletion in neuronal cells: relevance to Parkinson's disease. Biochem Pharmacol 1998;56:645-55.
  • 14: Pearce RK, Owen A, Daniel S, et al. Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease. J Neural Transm 1997;104:661-77.
  • 15: The lancet 344 :796-798,1994
  • 16: Samiec PS, Drews-Botsch C, Flagg EW, et al (1998). Glutathione in human plasma: decline in association with aging, age-related macular degeneration, and diabetes. Free Radic Biol Med. 24:699-704.
  • 17: 17 : Adams JD Jr, Klaidman LK, Odunze IN, Shen HC, Miller CA (1991). Alzheimer’s and Parkinson’s Disease. Brain levels of glutathione, glutathione disulfide, and vitamin E. Mol Clin Neuropathol. 14:213-226.
  • 18: Bains JS, Shaw CA (1997). Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death. Brain Res Brain Res Rev. 25:335-58.
  • 19: Chiang GC, Mao X, Kang G, Chang E, Pandya S, Vallabhajosula S, Isaacson R, Ravdin LD (2017). Alzheimer's Disease Neuroimaging Initiative, Shungu DC2. Relationships among Cortical Glutathione Levels, Brain Amyloidosis, and Memory in Healthy Older Adults Investigated In Vivo with 1H-MRS and Pittsburgh Compound-B PET. AJNR Am J Neuroradiol. 38(6):1130-1137.
  • 20: Lands LC, Grey V, Smountas AA, Kramer VG, McKenna D (1999). Lymphocyte glutathione levels in children with cystic fibrosis. Chest. 116(1):201-5.
  • 21: Clinical science 91 :575-582, 1996
  • 22: Fidelus RK, Tsan MF. Glutathione and lymphocyte activation: a function of aging and auto-immune disease. Immunology 1987; 61:503-50.
  • 23: Wu D. Meydani SN, Sastre J, et al (1994). In vitro glutathione supplementation enhances interleukin-2 production and mitogenic response of peripheral blood mononuclear cells from young and old subjects. J Nutr. 124:655-663.
  • 24: Droge W, Holm E (1997). Role of cysteine and glutathione in HIV infection and other diseases associated with muscle wasting and immunological dysfunction. FASEB J. 11:1077-89.
  • 25: Herzenberg LA, De Rosa SC, Dubs JG, et al (1997). Glutathione deficiency is associated with impaired survival in HIV disease. Proc Natl Acad Sci USA. 94:1967-72.
  • 26: Bounous G, Batist G, Gold P (1991). Whey proteins in cancer prevention. Cancer Lett. 57(2):91-4.
  • 27: Flagg EW, Coates RJ, Jones DP, et al (1994). Dietary glutathione intake and the risk of oral and pharyngeal cancer. Am J Epidemiol. 139:453-65.
  • 28: Flagg EW, Coates RJ, Jones DP, et al (1994). Dietary glutathione intake and the risk of oral and pharyngeal cancer. Am J Epidemiol. 139:453-65.
  • 29: 🔗 https://examine.com/supplements/glutathione/research/
  • 30: Hong SY, Gil HW, Yang JO, Lee EY, Kim HK, Kim SH, Chung YH, Hwang SK, Lee ZW (2005). Pharmacokinetics of glutathione and its metabolites in normal subjects. J Korean Med Sci. 20(5):721-6.
  • 31: Witschi A, Reddy S, Stofer B, et al (1992). The systemic availability of oral glutathione. Eur J Clin Pharmacol. 43:667-9.
  • 32: Hunjan MK, Evered DF. Absorption of glutathione from the gastrointestinal tract. Biochim Biophys Acta 1985;815:184-188.
  • 33: Amores-Sanchez MI, Medina MA (1999). Glutamine, as a precursor of glutathione, and oxidative stress. Mol Genet Metab. 67:100-5.
  • 34: Ruffmann R, Wendel A (1991). GSH rescue by N-acetylcysteine. Klin Wochenschr. 69:857-62.
  • 35: Meister A (1992). On the antioxidant effects of ascorbic acid and glutathione. Biochem Pharmacol. 1992. 44(10):1905-15.
  • 36: Meister A (1994). Glutathione, ascorbate, and cellular protection. Cancer Res (Suppl). 54:1969S-1975S.
  • 37: Niki, E., Tsuchiya. J., Tanimura, R and Kamiya. Y (1982). Regeneration of vitamin E from a-chromanoyl radical by glutathione and vitamin C. Chem. Lett. Jpn., 23: 789-792, 41.
  • 38: Reddy, C. C., Scholz. R. W. Thomas, C. E.. and Massaro, E. J (1982). Vitamin E dependent reduced glutathione inhibition of rat liver microsomal lipid peroxidation. Life Sci. 31: 571-576.
  • 39: Wefers H. and Sics. H (1988). The protection by ascorbate and glulathione against microsomal lipid peroxidation is dependent on vitamin E. Eur. J. Biochem. 174: 353-357.
  • 40: Lecdlc R. A., and Aust, S. D (1990). The effect of glutathione on the vitamin E requirement for inhibition of liver chromosomal lipid peroxidation. Lipids, 25: 241-245.
  • 41: Meister A (1994). Glutathione, ascorbate, and cellular protection. Cancer Res (Suppl). 54:1969S-1975S.
  • 42: Datta K, Roy SK, Mitra AK, Kulkarni AP (1994). Glutathione S-transferase mediated detoxification and bioactivation of xenobiotics during early human pregnancy. Early Hum Dev. 37(3):167-74.
  • 43: Marrades RM, Roca J, Barbera JA, et al. (1997). Nebulized glutathione induces bronchoconstriction in patients with mild asthma. Am J Respir Crit Care Med. 156(2 Pt 1):425-30.
  • 44: Kern JK, Geier DA, Adams JB, Garver CR, Audhya T, Geier MR (2011). A clinical trial of glutathione supplementation in autism spectrum disorders. Med Sci Monit. 17(12):CR677-82.

Mounir Belkouch

Mounir Belkouch, Auteur

Rédacteur scientifique nutrition et santé – Biochimiste de formation et Doctorat en neurosciences – Chercheur pendant 11 ans ayant publié plusieurs études - Titulaire d'un DIU en Phytothérapie / Aromathérapie de l'Université de Paris.

Partager cet article
Repost0
Pour être informé des derniers articles, inscrivez vous :